Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Nivolumab 24pembrolizumab 23Ipilimumab 17Specimen Handling 16Magnetic Resonance Spectroscopy 10CTLA-4 Antigen 8Opdualag 7relatlimab 6Cyclophosphamide 6binimetinib 5Paclitaxel 5Biopsy 5trametinib 4fludarabine phosphate 4fludarabine 4cemiplimab 4Carboplatin 4lifileucel 3dabrafenib 3atezolizumab 3X-Rays 3Taxes 3Standard of Care 3Radiotherapy 3Radiation 3Pemetrexed 3Introns 3Interferon alpha-2 3Immunoglobulin G 3Gemcitabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Particle Accelerators × Dermatologic × 30 days × Clear all
NCT07608549 2026-05-27

FLASH Pilot Phase 1 Safety Study

Dartmouth-Hitchcock Medical Center

Phase NA Not yet recruiting
10 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡